These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [The so-called "contact" system of plasma: consequences of the activation of the Hageman factor]. Damas J; Adam A Ann Biol Clin (Paris); 1988; 46(3):185-9. PubMed ID: 3044204 [TBL] [Abstract][Full Text] [Related]
28. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis. Herold R; Straub PW J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394 [No Abstract] [Full Text] [Related]
29. [Hageman enzyme as a trigger of blood kininogenesis systems]. Buluk K; Czokalo M; Zuch A Pol Arch Med Wewn; 1973 May; 50(5):475-80. PubMed ID: 4270098 [No Abstract] [Full Text] [Related]
30. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII). Niwano H; Embury PB; Greenberg BD; Ratnoff OD J Lab Clin Med; 1995 Feb; 125(2):251-6. PubMed ID: 7844473 [TBL] [Abstract][Full Text] [Related]
31. Activation of plasma Hageman factor and kallikrein in ongoing allergic reactions in the skin. Atkins PC; Miragliotta G; Talbot SF; Zweiman B; Kaplan AP J Immunol; 1987 Oct; 139(8):2744-8. PubMed ID: 3655370 [TBL] [Abstract][Full Text] [Related]
32. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways. Munkvad S Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763 [TBL] [Abstract][Full Text] [Related]
33. Role of Factor XII in hemostasis and thrombosis: clinical implications. Renné T; Gailani D Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651 [TBL] [Abstract][Full Text] [Related]
34. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795 [TBL] [Abstract][Full Text] [Related]
35. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin. Saito H; Ratnoff OD; Marshall JS; Pensky J J Clin Invest; 1973 Apr; 52(4):850-61. PubMed ID: 4266422 [TBL] [Abstract][Full Text] [Related]
36. Studies on contact activation: effects of surface and inhibitors. Cameron CL; Fisslthaler B; Sherman A; Reddigari S; Silverberg M Med Prog Technol; 1989; 15(1-2):53-62. PubMed ID: 2530427 [TBL] [Abstract][Full Text] [Related]
37. Studies on the participation of Hageman factor in fibrinolysis. McDonagh RP; Ferguson JH Thromb Diath Haemorrh; 1970 Oct; 24(1):1-9. PubMed ID: 4249468 [No Abstract] [Full Text] [Related]
38. The "Hageman" connection: interrelationships of blood coagulation, fibrino(geno)lysis, kinin generation, and complement activation. Murano G Am J Hematol; 1978; 4(4):409-17. PubMed ID: 362910 [TBL] [Abstract][Full Text] [Related]
39. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor). Schousboe I Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361 [TBL] [Abstract][Full Text] [Related]